These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 38510751)

  • 21. Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines.
    Guo W; Tan HY; Chen F; Wang N; Feng Y
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32050640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway.
    Liu X; Su K; Sun X; Jiang Y; Wang L; Hu C; Zhang C; Lu M; Du X; Xing B
    J Exp Clin Cancer Res; 2021 Apr; 40(1):132. PubMed ID: 33858476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role.
    Kannampuzha S; Gopalakrishnan AV
    Med Oncol; 2023 Aug; 40(9):264. PubMed ID: 37550533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway.
    Li M; Shan W; Hua Y; Chao F; Cui Y; Lv L; Dou X; Bian X; Zou J; Li H; Lin W
    Front Cell Dev Biol; 2021; 9():661602. PubMed ID: 34136482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy.
    Bhoopathi P; Mannangatti P; Das SK; Fisher PB; Emdad L
    Adv Cancer Res; 2023; 159():285-341. PubMed ID: 37268399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Ca
    Panda S; Chatterjee O; Roy L; Chatterjee S
    Drug Discov Today; 2022 Mar; 27(3):923-934. PubMed ID: 34793973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deciphering the Role of Ca
    Alharbi A; Zhang Y; Parrington J
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
    Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
    Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
    [No Abstract]   [Full Text] [Related]  

  • 31. Subtype specific targeting of calcium signaling in breast cancer.
    Makena MR; Rao R
    Cell Calcium; 2020 Jan; 85():102109. PubMed ID: 31783287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer.
    Assidicky R; Tokat UM; Tarman IO; Saatci O; Ersan PG; Raza U; Ogul H; Riazalhosseini Y; Can T; Sahin O
    Breast Cancer Res Treat; 2022 Jun; 193(2):331-348. PubMed ID: 35338412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular mechanisms of chemoresistance in cancers.
    Zheng HC
    Oncotarget; 2017 Aug; 8(35):59950-59964. PubMed ID: 28938696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer.
    Mukherjee S; Bhatti GK; Chhabra R; Reddy PH; Bhatti JS
    Biomed Pharmacother; 2023 Apr; 160():114398. PubMed ID: 36773523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Chemoresistance; Recent Challenges and Future Considerations.
    Adil M; Kanwal S; Rasheed S; Iqbal M; Abbas G
    Cancer Treat Res; 2023; 185():237-253. PubMed ID: 37306912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-coated albumin-paclitaxel nanoparticles loaded with sorcin-siRNA reverse cancer chemoresistance via restoring intracellular calcium ion homeostasis.
    Wang C; Xu X; Zhang P; Xiong S; Yuan J; Gao X; Guan W; Wang F; Li X; Dou H; Xu G
    J Nanobiotechnology; 2022 Jul; 20(1):319. PubMed ID: 35799174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crosstalk between Ca
    Kouba S; Hague F; Ahidouch A; Ouadid-Ahidouch H
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the Therapeutic Potential of Membrane Transport Proteins: Focus on Cancer and Chemoresistance.
    Almasi S; El Hiani Y
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
    Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
    Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling within the epithelial ovarian cancer tumor microenvironment: the challenge of tumor heterogeneity.
    Horowitz M; Esakov E; Rose P; Reizes O
    Ann Transl Med; 2020 Jul; 8(14):905. PubMed ID: 32793749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.